DR. CHARLES E BROCK M.D. NPI 1689761280

NPI Details

DR. Charles E Brock, M.D. is a family medicine in Cleveland, MS with 39 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Charles E Brock, M.D. NPI is 1689761280. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE
Graduation Year:1986

The provider's business location address is:

810 E SUNFLOWER RD
CLEVELAND, MS
ZIP 38732-800
Phone: (662) 843-3606

The NPI 1689761280 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, denosumab, 1 mg (HCPCS:J0897)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Hemoglobin a1c level (HCPCS:83036)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Vitamin d-3 level (HCPCS:82306)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Automated urinalysis test (HCPCS:81003)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Urine microalbumin (protein) analysis (HCPCS:82044)
• Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• X-ray of chest, 2 views (HCPCS:71046)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
• Critical care, first 30-74 minutes (HCPCS:99291)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose (HCPCS:J7321)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Initial nursing facility visit per day, typically 45 minutes (HCPCS:99306)
• Blood test, clotting time (HCPCS:85610)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Folic acid level, serum (HCPCS:82746)
• Iron level (HCPCS:83540)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
• Magnesium level (HCPCS:83735)
• Nursing facility discharge day management, 30 minutes or less (HCPCS:99315)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Ultrasound of leg arteries or artery grafts (HCPCS:93925)
• Uric acid level, blood (HCPCS:84550)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Hospital observation care on day of discharge (HCPCS:99217)
• X-ray of shoulder, 1 view (HCPCS:73020)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
• Initial hospital observation care per day, typically 70 minutes (HCPCS:99220)
• X-ray of hip, 2-3 views (HCPCS:73502)
• Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• Initial nursing facility visit per day, typically 35 minutes (HCPCS:99305)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Injection, lidocaine hcl for intravenous infusion, 10 mg (HCPCS:J2001)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
• Initial hospital observation care per day, typically 50 minutes (HCPCS:99219)
• X-ray of knee, 3 views (HCPCS:73562)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• X-ray of foot, 2 views (HCPCS:73620)
• Complete ultrasound scan of abdomen (HCPCS:76700)

The enumeration date for this NPI number is 10/6/2006 and was last updated on 7/8/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.